Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Y. Sunakawa · SciRah

Researcher profile · Semantic Scholar

Y. Sunakawa

Share profile

Y. Sunakawa — researcher profile on SciRah

h-index: 31
Works: 362
Citations: 3,597

Most-cited papers

Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study
Yoshiaki Nakamura, N. Mizuno, Y. Sunakawa, J. Canon +24 more
2023Journal of Clinical Oncology92 citations Open access
Semantic Scholar
Microsatellite instability: A 2024 update
Hiroyuki Yamamoto, Yoshiyuki Watanabe, Hiroyuki Arai, K. Umemoto +2 more
2024Cancer Science70 citations Open access
Semantic Scholar
Targeted therapy guided by circulating tumor DNA analysis in advanced gastrointestinal tumors
Yoshiaki Nakamura, Hiroshi Ozaki, M. Ueno, Y. Komatsu +25 more
2024Nature Medicine55 citations Open access
Semantic Scholar
Trastuzumab Deruxtecan in Advanced Solid Tumors With Human Epidermal Growth Factor Receptor 2 Amplification Identified by Plasma Cell-Free DNA Testing: A Multicenter, Single-Arm, Phase II Basket Trial
M. Yagisawa, H. Taniguchi, T. Satoh, S. Kadowaki +17 more
2024Journal of Clinical Oncology31 citations Open access
Semantic Scholar
Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer
K. Umemoto, Y. Sunakawa, M. Ueno, M. Furukawa +22 more
2023British Journal of Cancer29 citations Open access
Semantic Scholar
Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial
A. Okines, G. Curigliano, N. Mizuno, Do-Youn Oh +27 more
2025Nature Medicine28 citations Open access
Semantic Scholar
Addition of docetaxel to S-1 results in significantly superior 5-year survival outcomes in Stage III gastric cancer: a final report of the JACCRO GC-07 study
Y. Kodera, Kazuhiro Yoshida, M. Kochi, T. Sano +5 more
2023Gastric Cancer28 citations Open access
Semantic Scholar
Validity and utility of blood tumor mutational burden (bTMB) is dependent on circulating tumor DNA (ctDNA) shed: SCRUM-Japan MONSTAR-SCREEN
S. Mishima, Yoshiaki Nakamura, H. Tukachinsky, H. Taniguchi +19 more
2023The journal of liquid biopsy26 citations Open access
Semantic Scholar
Comprehensive review of undifferentiated carcinoma of the pancreas: from epidemiology to treatment
H. Imaoka, M. Ikeda, K. Umemoto, Y. Sunakawa +20 more
2023Japanese Journal of Clinical Oncology25 citations Open access
Semantic Scholar
Soluble programmed cell death ligand 1 predicts prognosis for gastric cancer patients treated with nivolumab: Blood-based biomarker analysis for the DELIVER trial.
H. Kawakami, Y. Sunakawa, E. Inoue, R. Matoba +19 more
2023European Journal of Cancer21 citations Open access
Semantic Scholar
Modified FOLFOXIRI plus cetuximab versus bevacizumab in RAS wild-type metastatic colorectal cancer: a randomized phase II DEEPER trial
M. Shiozawa, Y. Sunakawa, Takanori Watanabe, Hirofumi Ota +16 more
2024Nature Communications19 citations Open access
Semantic Scholar
A phase 3 study of first-line sotorasib, panitumumab, and FOLFIRI versus FOLFIRI with or without bevacizumab-awwb for patients with KRAS G12C–mutated metastatic colorectal cancer (CodeBreaK 301).
T. W. Kim, T. Price, Julieta Grasselli, J. Strickler +7 more
2025Journal of Clinical Oncology17 citations
Semantic Scholar
Tissue-agnostic efficacy of trastuzumab deruxtecan (T-DXd) in advanced solid tumors with HER2 amplification identified by plasma cell-free DNA (cfDNA) testing: Results from a phase 2 basket trial (HERALD/EPOC1806).
H. Taniguchi, M. Yagisawa, T. Satoh, S. Kadowaki +16 more
2023Journal of Clinical Oncology16 citations Open access
Semantic Scholar
Clinical features associated with NeoRAS wild-type metastatic colorectal cancer A SCRUM-Japan GOZILA substudy
H. Osumi, E. Shinozaki, Yoshiaki Nakamura, T. Esaki +16 more
2024Nature Communications15 citations Open access
Semantic Scholar
Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trial
Y. Kuboki, T. Terazawa, T. Masuishi, Masato Nakamura +20 more
2023British Journal of Cancer14 citations Open access
Semantic Scholar
Tucatinib and trastuzumab for previously treated HER2-positive metastatic biliary tract cancer (SGNTUC-019): A phase 2 basket study.
Yoshiaki Nakamura, N. Mizuno, Y. Sunakawa, E. Hamilton +15 more
2023Journal of Clinical Oncology12 citations
Semantic Scholar
Efficacy of Targeted Trials and Signaling Pathway Landscape in Advanced Gastrointestinal Cancers From SCRUM-Japan GI-SCREEN: A Nationwide Genomic Profiling Program
Yoshiaki Nakamura, Riu Yamashita, W. Okamoto, Y. Komatsu +32 more
2023JCO Precision Oncology11 citations Open access
Semantic Scholar
Clinical utility of geriatric assessment tools in older patients with gastrointestinal cancer
A. Doi, T. Mizukami, Hiroyuki Takeda, K. Umemoto +5 more
2023Frontiers in Oncology10 citations Open access
Semantic Scholar
Clinical Validation of Plasma-Based Genotyping for RAS and BRAF V600E Mutation in Metastatic Colorectal Cancer: SCRUM-Japan GOZILA Substudy
Yuji Aoki, Yoshiaki Nakamura, T. Denda, T. Ohta +25 more
2023JCO Precision Oncology9 citations Open access
Semantic Scholar
Real-World Evidence of FOLFIRI Combined with Anti-Angiogenesis Inhibitors or Anti-EGFR Antibodies for Patients with Early Recurrence Colorectal Cancer After Adjuvant FOLFOX/CAPOX Therapy: A Japanese Claims Database Study
Y. Kagawa, Chao-Chen Wang, Y. Piao, Long Jin +3 more
2024Targeted oncology8 citations Open access
Semantic Scholar
Longitudinal ctDNA monitoring and prediction of anti-EGFR rechallenge outcomes in RAS/BRAF wild-type metastatic colorectal cancer (mCRC): The REMARRY & PURSUIT trials.
Y. Kagawa, H. Taniguchi, D. Kotani, T. Hashimoto +16 more
2025Journal of Clinical Oncology6 citations
Semantic Scholar
Efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer: a FRESCO-2 subgroup analysis of patients enrolled in Japan
D. Kotani, T. Yoshino, T. Masuishi, Y. Sunakawa +14 more
2025International Journal of Clinical Oncology5 citations Open access
Semantic Scholar
A Multicenter, Phase II Trial of Schedule Modification for Nab-Paclitaxel in Combination with Ramucirumab for Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer: The B-RAX Trial (JACCRO GC-09)
R. Kawabata, N. Izawa, Takahisa Suzuki, Y. Nagahisa +17 more
2023Targeted oncology5 citations
Semantic Scholar
Efficacy and Tolerability of Zenocutuzumab in Advanced NRG1 Fusion–Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial
J. Cleary, C. Springfeld, Dirk Arnold, A. Hollebecque +16 more
2026Journal of Clinical Oncology4 citations Open access
Semantic Scholar
Clinical and Diagnostic Utility of Genomic Profiling for Digestive Cancers: Real-World Evidence from Japan
Marin Ishikawa, Kohei Nakamura, R. Kawano, Hideyuki Hayashi +23 more
2024Cancers4 citations Open access
Semantic Scholar
Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer
Hiroyuki Arai, Yan Yang, Y. Baca, J. Millstein +28 more
2024European Journal of Cancer4 citations Open access
Semantic Scholar
Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer
Y. Sunakawa, Y. Kuboki, J. Watanabe, T. Terazawa +20 more
2024Targeted oncology4 citations Open access
Semantic Scholar
An approach for improvement of the accuracy of cancer gene panel testing
K. Imoto, Hiroyuki Yamamoto, Chie Ohkawa, Naoki Shimada +15 more
2024International Journal of Clinical Oncology4 citations
Semantic Scholar
Role of plasma angiogenesis factors in the efficacy of first‐line chemotherapy combined with biologics in RAS wild‐type metastatic colorectal cancer: Results from the GI‐SCREEN CRC‐Ukit study
S. Yuki, K. Yamazaki, Y. Sunakawa, H. Taniguchi +17 more
2023Cancer Medicine4 citations Open access
Semantic Scholar
Real-World Genomic Landscape of Gastrointestinal Cancers in Asia and the Middle East Using Comprehensive Circulating Tumor DNA Next-Generation Sequencing
Manabu Muto, Y. Sunakawa, N. Sandhir, Yi-Hsin Liang +4 more
2025Oncology Research and Treatment3 citations Open access
Semantic Scholar
Tumor Response Predicts Survival Time of Nivolumab Monotherapy for Advanced Gastric Cancer: A Subgroup Analysis of the DELIVER Trial (JACCRO GC-08)
Y. Sunakawa, Y. Sakamoto, R. Kawabata, A. Ishiguro +14 more
2024The Oncologist3 citations Open access
Semantic Scholar
Second-line tislelizumab versus chemotherapy in Japanese patients with advanced or metastatic esophageal squamous cell carcinoma: subgroup analysis from RATIONALE-302
H. Hara, T. Satoh, T. Kojima, T. Tsushima +8 more
2024Esophagus3 citations Open access
Semantic Scholar
Phase Ia/Ib trial on the safety and efficacy of mobocertinib in combination with T-DM1 for patients with HER2-mutant solid tumors (WJOG16022M).
Hiroaki Kanemura, J. Tanizaki, K. Matsumoto, T. Masuishi +8 more
2024Journal of Clinical Oncology3 citations Open access
Semantic Scholar
Modified (m)-FOLFOXIRI plus cetuximab versus m-FOLFOXIRI plus bevacizumab as initial treatment of patients with unresectable RAS and BRAF wild-type metastatic colorectal cancer: Survival analysis of the phase II randomized DEEPER trial by JACCRO.
Y. Sunakawa, M. Shiozawa, Takanori Watanabe, H. Ota +16 more
2023Journal of Clinical Oncology3 citations
Semantic Scholar
The BEETS (JACCRO CC-18) trial: an observational and translational study of BRAF-mutated metastatic colorectal cancer.
C. Inagaki, R. Matoba, S. Yuki, M. Shiozawa +6 more
2023Future Oncology3 citations
Semantic Scholar
An observational/translational study to conduct real-world evidence and develop biomarkers of fruquintinib for patients with metastatic colorectal cancer (mCRC): FruBLOOM trial (JACCRO CC-19).
Y. Sunakawa, Chiaki Inagaki, S. Yuki, K. Ouchi +6 more
2025Journal of Clinical Oncology2 citations
Semantic Scholar
Benefits of Combining Circulating Tumor DNA With Tissue and Longitudinal Circulating Tumor DNA Genotyping in Advanced Solid Tumors: SCRUM-Japan MONSTAR-SCREEN-1 Study
T. Fujisawa, Yoshiaki Nakamura, H. Bando, C. Morizane +38 more
2025JCO Precision Oncology2 citations Open access
Semantic Scholar
Circulating Tumor DNA Profiling Reveals Genomic Evolution in Recurrent Gastric or Gastroesophageal Junction Cancer
R. Kawabata, Hiroyuki Takeda, Atsushi Ishiguro, S. Nishina +15 more
2025Molecular Diagnosis & Therapy2 citations
Semantic Scholar
Efficacy of Adding Immune Checkpoint Inhibitors to Chemotherapy Plus Bevacizumab in Metastatic Colorectal Cancer: A Meta-Analysis of Randomized Controlled Trials
Fumihiko Ando, A. Matsuda, Yuji Miyamoto, Y. Sunakawa +3 more
2025Cancers2 citations Open access
Semantic Scholar
Plasma Angiogenic Factors as Predictors of the Efficacy of Second-line Chemotherapy Combined with Angiogenesis Inhibitors in Metastatic Colorectal Cancer: Results From the GI-SCREEN CRC-Ukit Study.
S. Yuki, K. Yamazaki, Y. Sunakawa, H. Taniguchi +17 more
2024Clinical colorectal cancer2 citations Open access
Semantic Scholar
Quality-of-life survey of pancreatic cancer patients: a comparison between general public and physicians
Y. Sasahara, Y. Takumoto, Kaname Watanabe, Hiroyuki Takeda +9 more
2024Frontiers in Health Services2 citations Open access
Semantic Scholar
Genomic Profiling of Small Intestine Cancers From a Real-World Data Set Identifies Subgroups With Actionable Alterations
Hiroyuki Takeda, Hiroyuki Yamamoto, R. Oikawa, K. Umemoto +13 more
2024JCO Precision Oncology2 citations
Semantic Scholar
Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab based on early tumor shrinkage in RAS wild‐type metastatic colorectal cancer: A phase II trial (HYBRID)
Hiroyuki Arai, Takashi Tsuda, Y. Sunakawa, Mototsugu Shimokawa +12 more
2024Cancer Medicine2 citations Open access
Semantic Scholar
Results from the phase 1b/2 SGNTUC-024 study: Assessment of tucatinib, trastuzumab, and FOLFOX for HER2+ GI cancers.
Haeseong Park, T. Bekaii-Saab, Sunnie S. Kim, M. Pishvaian +14 more
2024Journal of Clinical Oncology2 citations
Semantic Scholar
The Molecular Landscape of Gastric Cancers for Novel Targeted Therapies from Real-World Genomic Profiling
Hiroyuki Yamamoto, Hiroyuki Arai, R. Oikawa, K. Umemoto +10 more
2024Targeted oncology2 citations
Semantic Scholar
NeoRAS wild-type metastatic colorectal cancer in the SCRUM-Japan GOZILA study.
H. Osumi, E. Shinozaki, Yoshiaki Nakamura, T. Esaki +16 more
2023Journal of Clinical Oncology2 citations
Semantic Scholar
Real-world outcomes of encorafenib, cetuximab ± binimetinib for BRAF‑mutated metastatic colorectal cancer: the BEETS (JACCRO CC‑18) study
D. Kotani, E. Inoue, T. Denda, Chiaki Inagaki +14 more
2026The Oncologist1 citations Open access
Semantic Scholar
Bridging the distance in precision oncology: a nationwide survey on institutional perspectives toward telemedicine and decentralized trials in Japan
H. Taniguchi, T. Kawakami, Hironaga Satake, Yuko Tamura +2 more
2026International Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Safety run-in results from C-SOLVE (JACCRO GC-12): A randomized, non-comparative phase II trial of CapeOX or SOX plus zolbetuximab in patients with HER2-negative, CLDN18.2-positive unresectable advanced gastric or GEJ cancer.
H. Kawakami, S. Yuki, R. Kawabata, Sho Sato +16 more
2026Journal of Clinical Oncology1 citations Open access
Semantic Scholar
JAGUAR (JACCRO PM-01): A prospective study to evaluate the clinical utility of serial comprehensive genomic profiling testing using circulating tumor DNA in patients with metastatic colorectal cancer.
Y. Sunakawa, T. Masuishi, Hiroyuki Takeda, Sho Umegaki +12 more
2026Journal of Clinical Oncology1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

H. Taniguchi×15
Invite
H. Taniguchi — researcher profile on SciRah
T. Nishina×13
Invite
T. Nishina — researcher profile on SciRah
T. Esaki×12
Invite
T. Esaki — researcher profile on SciRah
T. Denda×12
Invite
T. Denda — researcher profile on SciRah

×12

Invite

H. Yasui — researcher profile on SciRah

Invite

S. Yuki — researcher profile on SciRah

Invite

T. Yoshino — researcher profile on SciRah

Yoshiaki Nakamura×8

Invite

Yoshiaki Nakamura — researcher profile on SciRah

Invite

K. Umemoto — researcher profile on SciRah

Invite

T. Kato — researcher profile on SciRah

Hiroyuki Takeda×7

Invite

Hiroyuki Takeda — researcher profile on SciRah

Yoshiaki Nakamura×6

Invite

Yoshiaki Nakamura — researcher profile on SciRah